2021 News

Infinity BiologiX, Cytox, and Vanguard Pharma announce the US launch of polygenic test to predict the risk of cognitive decline due to Alzheimer’s disease

21 September 2021: Piscataway, New Jersey; Oxford and Manchester, UK; Mahwah, New Jersey.  Today, Infinity BiologiX, LLC (IBX), Cytox Ltd, and Vanguard Pharma announce the launch of the IBX Alzheimer’s Risk Test, powered by ...

New study launched to investigate targeted treatments for Schizophrenia

Monument Therapeutics, in collaboration with the University of Nottingham, has announced a preclinical study to support the use of their non-invasive biomarker for cognitive impairment in schizophrenia.  Currently, there are no treatme...

Maxwellia strengthens its Marketing team with two new appointments

Maxwellia, the UK’s only company 100% dedicated to switching Rx to OTC medicines has created two new senior roles in its marketing team.  The team expansion follows the success of the recent landmark reclassification of the progestoge...

From our portfolio



viewview our portfolio

Our Team

Nick Wright


view complete team

Contact us

Tel: 01625 344300